1. Home
  2. DXCM

DXCM

DexCom Inc.

Logo DexCom Inc.

Health Care

Medical/Dental Instruments

Nasdaq

as 04-12-2024 10:30am EST

$
-
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.

Founded: 1999 Country:
United States
United States
Employees: N/A City: SAN DIEGO
Market Cap: 54.1B IPO Year: 2005
Target Price: $140.79 AVG Volume (30 days): 3.1M
Analyst Decision: Strong Buy Number of Analysts: 14
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: 1.30 EPS Growth: 58.54
52 Week Low/High: $74.75 - $142.00 Next Earning Date: 04-25-2024
Revenue: $3,622,300,000 Revenue Growth: 24.49%
Revenue Growth (this year): 21.8% Revenue Growth (next year): 18.99%

Share on Social Networks: